{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:38:50Z","timestamp":1760042330207},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.rcl.2006.07.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:34Z","timestamp":1168439314000},"page":"649-663","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Approach to the Prostate: An Update"],"prefix":"10.1016","volume":"44","author":[{"given":"Alexander","family":"Kutikov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Bruce","family":"Malkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcl.2006.07.003_bib1","series-title":"Campbell's urology","first-page":"41","article-title":"Anatomy of the lower urinary tract and male genitalia","author":"Brooks","year":"2002"},{"key":"10.1016\/j.rcl.2006.07.003_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-2353(2000)13:3<207::AID-CA9>3.0.CO;2-9","article-title":"Terminology of the prostate and related structures","volume":"13","author":"Wendell-Smith","year":"2000","journal-title":"Clin Anat"},{"key":"10.1016\/j.rcl.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pros.20149","article-title":"Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics","volume":"62","author":"Laczko","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.rcl.2006.07.003_bib4","series-title":"Campbell's urology","first-page":"1237","article-title":"The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles","author":"Partin","year":"2002"},{"key":"10.1016\/j.rcl.2006.07.003_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations","volume":"170","author":"American Urological Association","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(03)13073-5","article-title":"Benign prostatic hyperplasia","volume":"361","author":"Thorpe","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rcl.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0094-0143(21)00961-7","article-title":"Pathology of benign prostatic hyperplasia. Insight into etiology","volume":"17","author":"McNeal","year":"1990","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.rcl.2006.07.003_bib8","first-page":"340","article-title":"Origin and evolution of benign prostatic enlargement","volume":"15","author":"McNeal","year":"1978","journal-title":"Invest Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib9","series-title":"Campbell's urology","first-page":"1297","article-title":"Etiology, pathophysiology, epidemiology, and natrual history of benign prostatic hyperplasia","author":"Roehrborn","year":"2002"},{"issue":"Suppl 1","key":"10.1016\/j.rcl.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1464-410X.1998.0810s1029.x","article-title":"The pathophysiology of lower urinary tract symptoms in the ageing male population","volume":"81","author":"Lepor","year":"1998","journal-title":"Br J Urol"},{"issue":"Suppl 2","key":"10.1016\/j.rcl.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1464-410X.2000.00098.x","article-title":"Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms","volume":"86","author":"Schwinn","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib12","first-page":"21","article-title":"Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia","volume":"32","author":"Lepor","year":"1988","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib13","first-page":"640","article-title":"Alpha 1 adrenoceptor subtypes in the human prostate","volume":"149","author":"Lepor","year":"1993","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib14","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/01.ju.0000133655.71782.14","article-title":"Molecular and cellular pathogenesis of benign prostatic hyperplasia","volume":"172","author":"Lee","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.1997.tb00138.x","article-title":"Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score","volume":"4","author":"Homma","year":"1997","journal-title":"Int J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0090-4295(01)00965-7","article-title":"Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination","volume":"57","author":"Roehrborn","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(01)61785-3","article-title":"Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng.\/ml. or less","volume":"161","author":"Carvalhal","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-5347(05)67962-1","article-title":"Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study","volume":"163","author":"Roehrborn","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-4295(98)00654-2","article-title":"Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0090-4295(99)00232-0","article-title":"Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group","volume":"54","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0090-4295(01)01155-4","article-title":"Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials","volume":"58","author":"Roehrborn","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib24","series-title":"Campbell's urology updates","first-page":"1","article-title":"Medical management of BPH\u2014an update","author":"Walmsley","year":"2004"},{"key":"10.1016\/j.rcl.2006.07.003_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-5347(01)63011-8","article-title":"5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study","volume":"160","author":"Flanigan","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM199501123320202","article-title":"A\u00a0comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate","volume":"332","author":"Wasson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0302-2838(03)00084-8","article-title":"The natural history of lower urinary tract symptoms over five years","volume":"43","author":"Temml","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000020246","article-title":"Medical therapy for benign prostatic hyperplasia: a review of the literature","volume":"38","author":"Clifford","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bmj.323.7320.1042","article-title":"Benign prostatic hyperplasia","volume":"323","author":"Barry","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.rcl.2006.07.003_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00000658-189607000-00036","article-title":"The question of castration for enlarged prostate","volume":"24","author":"Cabot","year":"1896","journal-title":"Ann Surg"},{"key":"10.1016\/j.rcl.2006.07.003_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1464-410X.2004.05022.x","article-title":"Pharmacological therapy of benign prostatic hyperplasia\/lower urinary tract symptoms: an overview for the practising clinician","volume":"94","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000020181","article-title":"Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia","volume":"37","author":"Bartsch","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/jcem-71-6-1552","article-title":"Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen","volume":"71","author":"Geller","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rcl.2006.07.003_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-5347(01)62536-9","article-title":"The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group","volume":"160","author":"Lepor","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000020189","article-title":"Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group","volume":"37","author":"Roehrborn","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","article-title":"The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group","volume":"327","author":"Gormley","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rcl.2006.07.003_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.10.005","article-title":"Drug treatment for LUTS and BPH: new is not always better","volume":"49","author":"Roehrborn","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group","volume":"335","author":"Lepor","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000019706","article-title":"Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group","volume":"34","author":"Debruyne","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib42","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib43","series-title":"Campbell's urology","first-page":"1423","article-title":"Retropubic and suprapubic open prostatectomy","author":"Han","year":"2002"},{"key":"10.1016\/j.rcl.2006.07.003_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.eururo.2004.12.010","article-title":"Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases","volume":"47","author":"Madersbacher","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib45","series-title":"Campbell's urology","first-page":"1379","article-title":"Minimally invasive and endoscopic management of benign prostatic hyperplasia","author":"Fitzpatrick","year":"2002"},{"key":"10.1016\/j.rcl.2006.07.003_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-5347(17)40731-2","article-title":"Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients","volume":"141","author":"Mebust","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib47","first-page":"1","article-title":"Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research","author":"McConnell","year":"1994","journal-title":"Clin Pract Guidel Quick Ref Guide Clin"},{"key":"10.1016\/j.rcl.2006.07.003_bib48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ju.0000113494.03668.6d","article-title":"A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia","volume":"171","author":"Tooher","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000170230.26743.e4","article-title":"Holmium laser enucleation of the prostate for men with urinary retention","volume":"174","author":"Peterson","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib50","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-410X.2005.05775.x","article-title":"A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia","volume":"96","author":"Naspro","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1464-410X.2004.04598.x","article-title":"The development of laser prostatectomy","volume":"93","author":"Te","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib52","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.ju.0000139541.68542.f6","article-title":"Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial","volume":"172","author":"Te","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.ju.0000146631.14200.d4","article-title":"High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients","volume":"173","author":"Reich","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib54","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/01.ju.0000173913.41401.67","article-title":"Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes","volume":"174","author":"Malek","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1464-410X.2003.04474.x","article-title":"Long-term results of high-power holmium laser vaporization (ablation) of the prostate","volume":"92","author":"Tan","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib56","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2004.05099.x","article-title":"Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review","volume":"94","author":"Hoffman","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0090-4295(97)00277-X","article-title":"Transurethral needle ablation of the prostate","volume":"50","author":"Naslund","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4065\/80.7.899","article-title":"Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease","volume":"80","author":"Routh","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rcl.2006.07.003_bib59","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ejca.2004.12.029","article-title":"Screening for prostate cancer","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rcl.2006.07.003_bib60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jnci\/91.12.1025","article-title":"Cancer surveillance series: interpreting trends in prostate cancer\u2014part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality","volume":"91","author":"Feuer","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rcl.2006.07.003_bib61","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA: A Cancer Journal for Clinicians 2006;56:106\u201330.","DOI":"10.3322\/canjclin.56.2.106"},{"key":"10.1016\/j.rcl.2006.07.003_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","article-title":"Prostate specific antigen: a decade of discovery\u2014what we have learned and where we are going","volume":"162","author":"Polascik","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib63","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jnci\/91.12.1017","article-title":"Cancer surveillance series: interpreting trends in prostate cancer\u2014part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates","volume":"91","author":"Hankey","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rcl.2006.07.003_bib64","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.rcl.2006.07.003_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.critrevonc.2005.03.010","article-title":"Cancer of the prostate","volume":"56","author":"Bracarda","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.rcl.2006.07.003_bib66","first-page":"5","article-title":"Familial risk factors for prostate cancer","volume":"11","author":"Carter","year":"1991","journal-title":"Cancer Surv"},{"key":"10.1016\/j.rcl.2006.07.003_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)35617-3","article-title":"Hereditary prostate cancer: epidemiologic and clinical features","volume":"150","author":"Carter","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib68","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-5347(17)38074-6","article-title":"Familial patterns of prostate cancer: a case-control analysis","volume":"146","author":"Spitz","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/80.1.204","article-title":"Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer","volume":"80","author":"Leitzmann","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.rcl.2006.07.003_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ypmed.2004.10.022","article-title":"Phytoestrogens and prostate cancer risk","volume":"41","author":"Ganry","year":"2005","journal-title":"Prev Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib71","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.1991.210","article-title":"Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County","volume":"63","author":"Shimizu","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rcl.2006.07.003_bib72","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0090-4295(99)80076-4","article-title":"Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era","volume":"45","author":"McCormack","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1095\/biolreprod39.2.499","article-title":"Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30)","volume":"39","author":"McGee","year":"1988","journal-title":"Biol Reprod"},{"key":"10.1016\/j.rcl.2006.07.003_bib74","first-page":"222","article-title":"A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer","volume":"51","author":"Stenman","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.rcl.2006.07.003_bib75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib77","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.urology.2005.03.093","article-title":"Biopsy of men with PSA level of 2.6 to 4.0 ng\/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis","volume":"66","author":"Zhu","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.rcl.2006.07.003_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D'Amico","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-5347(17)38666-4","article-title":"The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations","volume":"142","author":"Shinohara","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(05)67367-3","article-title":"A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection","volume":"164","author":"Naughton","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib81","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(01)62255-9","article-title":"Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature","volume":"160","author":"Rodriguez","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib82","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0094-0143(05)70386-4","article-title":"Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control","volume":"24","author":"Pound","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.rcl.2006.07.003_bib83","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5347(17)40211-4","article-title":"Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen","volume":"143","author":"Cooner","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib84","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/cncr.1980.45.s7.1906","article-title":"Radical surgery for prostatic cancer","volume":"45","author":"Walsh","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.rcl.2006.07.003_bib85","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0025-6196(12)62725-6","article-title":"Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma","volume":"65","author":"Rainwater","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rcl.2006.07.003_bib86","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.277.18.1452","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination. Enhancement of specificity with free PSA measurements","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.rcl.2006.07.003_bib87","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.rcl.2006.07.003_bib88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-5347(01)67248-3","article-title":"A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer","volume":"154","author":"D'Amico","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib89","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.277.18.1445","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological\u00a0stage of localized prostate cancer. A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.rcl.2006.07.003_bib90","first-page":"1713","article-title":"Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy","volume":"32","author":"Terris","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib91","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00005392-199503001-00024","article-title":"The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy","volume":"153","author":"Wolf","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib92","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/01.ju.0000181224.95276.82","article-title":"Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer","volume":"174","author":"Mullerad","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib93","doi-asserted-by":"crossref","unstructured":"American Joint Committee on Cancer. Prostate. In: Greene, Frederick L, et\u00a0al. AJCC cancer staging manual. New York: Springer-Verlag; 2002. p. 309.","DOI":"10.1007\/978-1-4757-3656-4_34"},{"key":"10.1016\/j.rcl.2006.07.003_bib94","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-5347(05)65271-8","article-title":"Expectant management of nonpalpable prostate cancer with curative intent: preliminary results","volume":"167","author":"Carter","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib95","first-page":"1","article-title":"The results of watchful waiting for prostate cancer","volume":"24","author":"Allaf","year":"2005","journal-title":"AUA Update Series"},{"key":"10.1016\/j.rcl.2006.07.003_bib96","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ejca.2005.02.005","article-title":"Surgical management of prostate cancer: advances based on a rational approach to the data","volume":"41","author":"Meraney","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rcl.2006.07.003_bib97","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)53012-8","article-title":"Impotence following radical prostatectomy: insight into etiology and prevention","volume":"128","author":"Walsh","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib98","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0022-5347(05)66921-2","article-title":"Factors predicting recovery of erections after radical prostatectomy","volume":"164","author":"Rabbani","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib99","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.ju.0000154970.63147.90","article-title":"Laparoscopic radical prostatectomy","volume":"173","author":"Trabulsi","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000173940.49015.4a","article-title":"Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures","volume":"174","author":"Stolzenburg","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/14737140.6.1.11","article-title":"Robotic prostatectomy: a pooled analysis of published literature","volume":"6","author":"Tewari","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.rcl.2006.07.003_bib102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00345-003-0357-9","article-title":"Permanent interstitial brachytherapy for prostate cancer: a current review","volume":"21","author":"Woolsey","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib103","first-page":"9","article-title":"Complications of\u00a0permanent interstitial brachytherapy for carcinoma of the prostate","volume":"23","author":"Miller","year":"2004","journal-title":"AUA Update Series"},{"key":"10.1016\/j.rcl.2006.07.003_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2004.07.666","article-title":"Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative","volume":"62","author":"Morris","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rcl.2006.07.003_bib105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jjco\/hyi174","article-title":"Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer","volume":"35","author":"Hashine","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.rcl.2006.07.003_bib106","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ejca.2004.12.028","article-title":"Technological advances in radiotherapy for the treatment of localised prostate cancer","volume":"41","author":"Mangar","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rcl.2006.07.003_bib107","first-page":"145","article-title":"Current status of cryosurgery in the treatment of prostate cancer","volume":"23","author":"Horger","year":"2004","journal-title":"AUA Update Series"},{"key":"10.1016\/j.rcl.2006.07.003_bib108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1078-1439(03)00016-4","article-title":"The timing of hormone therapy for men with asymptomatic advanced prostate cancer","volume":"21","author":"Messing","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.rcl.2006.07.003_bib109","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/02841860510029743","article-title":"Endocrine therapy for prostate cancer","volume":"44","author":"Damber","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.rcl.2006.07.003_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00345-004-0482-0","article-title":"Chemotherapy for androgen-independent prostate cancer","volume":"23","author":"Petrylak","year":"2005","journal-title":"World J Urol"},{"key":"10.1016\/j.rcl.2006.07.003_bib111","first-page":"258","article-title":"The 2001 Giessen Cohort Study on patients with prostatitis syndrome\u2014an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis","volume":"35","author":"Schneider","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.rcl.2006.07.003_bib112","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.rcl.2006.07.003_bib113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1464-410X.2005.05373.x","article-title":"Prostate-related pain in patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"95","author":"Schneider","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0891-5520(03)00003-5","article-title":"Prostatitis revisited: new definitions, new approaches","volume":"17","author":"Krieger","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.rcl.2006.07.003_bib115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1464-410X.2004.05256.x","article-title":"Quantifying symptoms in men with interstitial cystitis\/prostatitis, and its correlation with potassium-sensitivity testing","volume":"95","author":"Parsons","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib116","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1464-410X.2004.05148.x","article-title":"The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence?","volume":"94","author":"Nickel","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.rcl.2006.07.003_bib117","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","article-title":"Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial","volume":"141","author":"Alexander","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rcl.2006.07.003_bib118","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1464-410X.2005.05922.x","article-title":"Promise for prostatitis?","volume":"96","author":"Wyllie","year":"2005","journal-title":"BJU Int"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838906000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838906000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T12:56:41Z","timestamp":1628341001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033838906000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0033838906000728"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2006.07.003","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}